News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,981 Results
Type
Article (43349)
Company Profile (439)
Press Release (678192)
Multimedia
Podcasts (89)
Webinars (16)
Section
Business (208962)
Career Advice (2029)
Deals (36055)
Drug Delivery (104)
Drug Development (83841)
Employer Resources (173)
FDA (16514)
Job Trends (15141)
News (353401)
Policy (33183)
Tag
Academia (2666)
Accelerated approval (11)
Adcomms (26)
Allergies (98)
Alliances (51136)
ALS (115)
Alzheimer's disease (1535)
Antibody-drug conjugate (ADC) (167)
Approvals (16492)
Artificial intelligence (328)
Autoimmune disease (33)
Automation (18)
Bankruptcy (373)
Best Places to Work (11850)
BIOSECURE Act (19)
Biosimilars (122)
Biotechnology (331)
Bladder cancer (98)
Brain cancer (35)
Breast cancer (373)
Cancer (2939)
Cardiovascular disease (225)
Career advice (1697)
Career pathing (30)
CAR-T (194)
CDC (32)
Cell therapy (523)
Cervical cancer (22)
Clinical research (68751)
Collaboration (1065)
Company closure (3)
Compensation (699)
Complete response letters (27)
COVID-19 (2687)
CRISPR (64)
C-suite (336)
Cystic fibrosis (117)
Data (3033)
Decentralized trials (2)
Denatured (31)
Depression (70)
Diabetes (352)
Diagnostics (6493)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (146)
Drug pricing (130)
Drug shortages (29)
Duchenne muscular dystrophy (131)
Earnings (88699)
Editorial (44)
Employer branding (21)
Employer resources (149)
Events (117406)
Executive appointments (873)
FDA (18177)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (973)
Gene editing (141)
Generative AI (23)
Gene therapy (405)
GLP-1 (824)
Government (4595)
Grass and pollen (4)
Guidances (181)
Healthcare (19190)
Huntington's disease (31)
IgA nephropathy (43)
Immunology and inflammation (163)
Immuno-oncology (8)
Indications (40)
Infectious disease (2862)
Inflammatory bowel disease (154)
Inflation Reduction Act (13)
Influenza (64)
Intellectual property (121)
Interviews (313)
IPO (16879)
IRA (47)
Job creations (3710)
Job search strategy (1439)
Kidney cancer (13)
Labor market (52)
Layoffs (524)
Leadership (19)
Legal (8006)
Liver cancer (80)
Lung cancer (413)
Lymphoma (211)
Machine learning (11)
Management (58)
Manufacturing (393)
MASH (94)
Medical device (13620)
Medtech (13625)
Mergers & acquisitions (19887)
Metabolic disorders (885)
Multiple sclerosis (99)
NASH (19)
Neurodegenerative disease (132)
Neuropsychiatric disorders (38)
Neuroscience (2252)
NextGen: Class of 2025 (6771)
Non-profit (4567)
Now hiring (47)
Obesity (450)
Opinion (237)
Ovarian cancer (102)
Pain (110)
Pancreatic cancer (121)
Parkinson's disease (194)
Partnered (22)
Patents (299)
Patient recruitment (164)
Peanut (51)
People (59106)
Pharmaceutical (86)
Pharmacy benefit managers (22)
Phase I (21602)
Phase II (30341)
Phase III (22405)
Pipeline (1649)
Policy (210)
Postmarket research (2611)
Preclinical (9293)
Press Release (67)
Prostate cancer (145)
Psychedelics (43)
Radiopharmaceuticals (272)
Rare diseases (488)
Real estate (6028)
Recruiting (67)
Regulatory (23127)
Reports (50)
Research institute (2435)
Resumes & cover letters (353)
Rett syndrome (9)
RNA editing (10)
RSV (49)
Schizophrenia (94)
Series A (168)
Series B (116)
Service/supplier (11)
Sickle cell disease (66)
Special edition (21)
Spinal muscular atrophy (153)
Sponsored (33)
Startups (3779)
State (2)
Stomach cancer (15)
Supply chain (77)
Tariffs (57)
The Weekly (56)
Vaccines (800)
Venture capital (55)
Weight loss (276)
Women's health (48)
Worklife (17)
Date
Today (36)
Last 7 days (393)
Last 30 days (1872)
Last 365 days (32083)
2025 (17147)
2024 (36314)
2023 (41037)
2022 (52312)
2021 (56794)
2020 (54951)
2019 (47471)
2018 (35732)
2017 (33073)
2016 (32428)
2015 (38466)
2014 (32283)
2013 (27219)
2012 (29322)
2011 (29939)
2010 (28074)
Location
Africa (739)
Alabama (67)
Alaska (7)
Arizona (251)
Arkansas (14)
Asia (39728)
Australia (6609)
California (7574)
Canada (2373)
China (693)
Colorado (328)
Connecticut (331)
Delaware (195)
Europe (86948)
Florida (1123)
Georgia (248)
Hawaii (1)
Idaho (59)
Illinois (658)
India (26)
Indiana (364)
Iowa (18)
Japan (230)
Kansas (111)
Kentucky (30)
Louisiana (15)
Maine (64)
Maryland (1041)
Massachusetts (5730)
Michigan (247)
Minnesota (456)
Mississippi (3)
Missouri (90)
Montana (30)
Nebraska (25)
Nevada (80)
New Hampshire (70)
New Jersey (2113)
New Mexico (30)
New York (2116)
North Carolina (1148)
North Dakota (9)
Northern California (3305)
Ohio (238)
Oklahoma (16)
Oregon (38)
Pennsylvania (1628)
Puerto Rico (17)
Rhode Island (37)
South America (1114)
South Carolina (34)
South Dakota (1)
Southern California (2819)
Tennessee (125)
Texas (1137)
United States (28187)
Utah (222)
Virginia (190)
Washington D.C. (74)
Washington State (654)
West Virginia (4)
Wisconsin (69)
721,981 Results for "cognition therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cognition Therapeutics Completes End-of-Phase 2 Meeting with FDA for Zervimesine (CT1812) in Alzheimer’s Disease
July 11, 2025
·
7 min read
Press Releases
Cognition Therapeutics Study of Zervimesine (CT1812) in Early Alzheimer’s Disease Surpasses 50% Enrollment Target
July 2, 2025
·
8 min read
Press Releases
Cognition Therapeutics Provides Regulatory Update on Zervimesine (CT1812) in Alzheimer’s Disease and Dementia with Lewy Bodies (DLB)
June 25, 2025
·
7 min read
Press Releases
Alpha Cognition Inc. Reports First Quarter 2025 Financial Results and Operating Overview
May 15, 2025
·
9 min read
Press Releases
Cognition Therapeutics Reports Financial Results for the First Quarter 2025 and Provides Business Update
May 7, 2025
·
8 min read
Press Releases
Cognition Therapeutics Releases New Episode of “Conversations” Podcast: Studying the Patient/Caregiver Lived Experience in Dementia with Lewy Bodies
May 28, 2025
·
4 min read
Press Releases
Philanthropic Donor Funds Cognition Therapeutics’ Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
June 3, 2025
·
7 min read
Press Releases
Cognition Therapeutics Presented Data at Association for Research in Vision and Ophthalmology Showing Impact on Retinal Cell Health
May 9, 2025
·
8 min read
Press Releases
Cognition Therapeutics to Present at Life Sciences Virtual Investor Conference
March 10, 2025
·
5 min read
Press Releases
Cognition Therapeutics to Report Fourth Quarter and Full Year 2024 Results
March 14, 2025
·
5 min read
1 of 72,199
Next
